Cooler Heads Care, Inc.

Cooler Heads Care, Inc. manufactures the Amma™ Scalp Cooling System, an FDA-cleared medical device designed to reduce chemotherapy-induced hair loss in cancer patients. The system is intended for adults 21 and older undergoing treatment for solid tumors. Amma consists of four integrated components: a custom-fitted cooling wrap that delivers chilled solution to the scalp, a neoprene compression strap, a compression cap for secure fit, and a portable cooling unit that circulates and maintains optimal temperature. The device operates by cooling the scalp before, during, and after chemotherapy administration, thereby reducing chemotherapy drug penetration to hair follicles and supporting hair preservation and regrowth. Treatment protocol requires cooling initiation 30 minutes before chemotherapy and continuation for 2–3 hours post-infusion. The Amma system is distinguished by its portability, allowing patients mobility throughout infusion centers, and features a custom-fitted wrap requiring no mid-session adjustments. The company provides comprehensive patient and clinical staff support through a dedicated customer care team, training tools, and clinical guidance. Cooler Heads has received backing from established accelerators and research institutions including StartX, Endless Frontier Labs, and the NIH National Cancer Institute, and is recognized by MedTech Innovator and the California Technology & Innovation Program. The product addresses multiple medical and psychosocial contraindications and requires provider prescription and infusion center availability.